Merck Diabetes Drugs Include Pancreatitis Risk: FDA
Januvia, also known as sitagliptin, and Janumet, known as sitagliptin/ metformin, are approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Sitagliptin is the first in a new class of diabetic drugs called dipeptidyl peptidase-4 inhibitors.
The FDA said Friday...
To view the full article, register now.